| Followers | 125 |
| Posts | 5424 |
| Boards Moderated | 0 |
| Alias Born | 06/09/2020 |
Saturday, February 12, 2022 8:40:52 AM
No, I’ve argued with plenty of links and a video clip on UCLA clinical trial that beyond doubt mention the combo GBM trial with Keytruda and where ATL-DC is DCVax-L.
I’ve never mentioned any lung cancer trial.
Adam Feuerstein tried to sow doubt about DCVax-L being used in this trial and as I documented, didn’t succeed.
But I am glad you agree, that it is DCVax-L under the guise of the generic name ATL-DC, that is being used in the combo trial with Pembrolizumab, Keytruda.
A gallimaufry of pulchritudinous terpsichorean burlesque, followed by a veritable floribundum of perfect and plentitudinous prestidigitation and a show of verisimilitudinous, violent, ventriloquial virtuosity.
Recent NWBO News
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
